Evolv Technologies stock rating reinstated as Buy by TD Cowen on growth outlook

TD Cowen has reinstated coverage on Evolv Technologies (EVLV) with a Buy rating and a $10 price target, citing improved fundamentals under new management, completed financial restatements, and diminishing regulatory concerns. This positive outlook is supported by Evolv's strong Q2 2025 results, which surpassed analyst expectations, and a raised FY2025 revenue guidance to $132-$135 million (27-30% YoY growth) alongside higher EBITDA margin targets. Despite these robust financial and operational improvements, the stock experienced a slight decline in after-hours trading.

Analysis

Evolv Technologies (EVLV) has received a significant vote of confidence from TD Cowen, which reinstated coverage with a Buy rating and a $10.00 price target, implying notable upside from its current trading level of $7.37. The reinstatement is underpinned by several key developments that de-risk the company's profile: the installation of new management, the completion of financial restatements, and diminishing regulatory concerns. This positive outlook is further substantiated by strong Q2 2025 financial results, where the company surpassed analyst expectations with an EPS of -$0.02 against a forecast of -$0.05 and revenue of $32.5 million versus an estimated $30.95 million. Demonstrating accelerating business momentum, management has raised its full-year 2025 revenue guidance to a range of $132 million to $135 million, representing a robust 27% to 30% year-over-year growth, an increase from the prior 20-25% forecast. Furthermore, the company has also lifted its EBITDA margin targets to mid-single digits, signaling a clearer path to profitability. Despite this collection of positive fundamental data and the stock's impressive 104% return over the past year, it did experience a minor decline in after-hours trading.

Key Decisions for Investors

• Investors should consider the reinstated Buy rating and $10 price target from TD Cowen, combined with the earnings beat and raised guidance, as a strong bullish signal reflecting a potential inflection point for the company.
• The resolution of key overhangs, including management changes and financial restatements, reduces historical investment risks and may warrant a reassessment of the company's long-term value.
• Given the stock's 104% appreciation over the past year, it is prudent to monitor whether the company can execute on its new, higher growth and profitability targets to justify its current valuation and sustain momentum.